Authors:
Melchior, SW
Noteboom, J
Gillitzer, R
Lange, PH
Blumenstein, BA
Vessella, RL
Citation: Sw. Melchior et al., The percentage of free prostate-specific antigen does not predict extracapsular disease in patients with clinically localized prostate cancer before radical prostatectomy, BJU INT, 88(3), 2001, pp. 221-225
Authors:
Brown, JM
Vessella, RL
Kostenuik, PJ
Dunstan, CR
Lange, PH
Corey, E
Citation: Jm. Brown et al., Serum osteoprotegerin levels are increased in patients with advanced prostate cancer, CLIN CANC R, 7(10), 2001, pp. 2977-2983
Citation: Dg. Mcneel et al., Naturally occurring prostate cancer antigen-specific T cell responses of aTh1 phenotype can be detected in patients with prostate cancer, PROSTATE, 47(3), 2001, pp. 222-229
Citation: Ph. Lange, High-grade carcinoma of the prostate: A comparison of current local therapies - Editorial comment, UROLOGY, 57(6), 2001, pp. 1126-1127
Authors:
Thomas, R
True, LD
Lange, PH
Vessella, RL
Citation: R. Thomas et al., Placental bone morphogenetic protein (PLAB) gene expression in normal, pre-malignant and malignant human prostate: Relation to tumor development and progression, INT J CANC, 93(1), 2001, pp. 47-52
Authors:
Thomas, R
True, LD
Bassuk, JA
Lange, PH
Vessella, RL
Citation: R. Thomas et al., Differential expression of osteonectin/SPARC during human prostate cancer progression, CLIN CANC R, 6(3), 2000, pp. 1140-1149
Authors:
Baker, LH
Bahnson, RR
Hanks, GE
Huben, RP
Kantoff, P
Kozlowski, JM
Kuettel, M
Lange, PH
Logothetis, C
Pow-Sang, JM
Roach, M
Sandler, H
Scardino, PT
Taylor, RJ
Urban, DA
Walsh, PC
Wilson, TG
Citation: Lh. Baker et al., NCCN Practice Guidelines for prostate cancer, ONCOLOGY-NY, 14(11A), 2000, pp. 111-119
Authors:
Catalona, WJ
Southwick, PC
Slawin, KM
Partin, AW
Brawer, MK
Flanigan, RC
Patel, A
Richie, JP
Walsh, PC
Scardino, PT
Lange, PH
Gasior, GH
Loveland, KG
Bray, KR
Citation: Wj. Catalona et al., Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging, UROLOGY, 56(2), 2000, pp. 255-260
Authors:
Vessella, RL
Lange, PH
Partin, AW
Chan, DW
Sokoll, LJ
Sasse, EA
Crawford, ED
Citation: Rl. Vessella et al., Probability of prostate cancer detection based on results of a multicenterstudy using the AxSYM free PSA and total PSA assays, UROLOGY, 55(6), 2000, pp. 909-914
Authors:
Catalona, WJ
Partin, AW
Slawin, KM
Naughton, CK
Brawer, MK
Flanigan, RC
Richie, JP
Patel, A
Walsh, PC
Scardino, PT
Lange, PH
deKernion, JB
Southwick, PC
Loveland, KG
Parson, RE
Gasior, GH
Citation: Wj. Catalona et al., Percentage of free PSA in black versus white men for detection and stagingof prostate cancer: A prospective multicenter clinical trial, UROLOGY, 55(3), 2000, pp. 372-376
Authors:
McNeel, DG
Nguyen, LD
Storer, BE
Vessella, R
Lange, PH
Disis, ML
Citation: Dg. Mcneel et al., Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer, J UROL, 164(5), 2000, pp. 1825-1829
Authors:
Krieger, JN
Riley, DE
Vesella, RL
Miner, DC
Ross, SO
Lange, PH
Citation: Jn. Krieger et al., Bacterial DNA sequences in prostate tissue from patients with prostate cancer and chronic prostatitis, J UROL, 164(4), 2000, pp. 1221-1227
Authors:
Melchior, SW
Brown, LG
Figg, WD
Quinn, JE
Santucci, RA
Brunner, J
Thuroff, JW
Lange, PH
Vessella, RL
Citation: Sw. Melchior et al., Effects of phenylbutyrate on proliferation and apoptosis in human prostatecancer cells in vitro and in vivo, INT J ONCOL, 14(3), 1999, pp. 501-508
Citation: Ra. Santucci et al., Continence and urodynamic parameters of continent urinary reservoirs: Comparison of gastric, ileal, ileocolic, right colon, and sigmoid segments, UROLOGY, 54(2), 1999, pp. 252-257
Authors:
Southwick, PC
Catalona, WJ
Partin, AW
Slawin, KM
Brawer, MK
Flanigan, RC
Patel, A
Richie, JP
Walsh, PC
Scardino, PT
Lange, PH
Gasior, GH
Parson, RE
Loveland, KG
Citation: Pc. Southwick et al., Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: A prospective multicenter clinical trial, J UROL, 162(4), 1999, pp. 1346-1351